Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
This trial will study if ephedrine pretreatment before low doses of rocuronium (0.6 or 0.8 mg/kg) would provide similar intubating conditions as with the high dose of 1.2 mg/kg in patients undergoing RSII.
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| ER6 | Experimental | to receive rocuronium 0.6 mg/kg with ephedrine pretreatment |
|
| ER8 | Experimental | to receive rocuronium 0.8 mg/kg with ephedrine pretreatment |
|
| R12 | Active Comparator | to receive rocuronium 1.2 mg/kg with no pretreatment |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| Ephedrine | Drug | 70 μg/kg as pretreatment |
| |
| Rocuronium 0.6 |
| Measure | Description | Time Frame |
|---|---|---|
| Intubation conditions | Evaluation of intubation conditions after rapid sequence induction using rocuronium 0.6 or 0.8 mg/kg with ephedrine pretreatment, compared with 1.2 mg/kg, according to the criteria of the Good Clinical Research Practice (GCRP) in pharmacodynamic studies of NMBAs (Fuchs-Buder et al., 2007), which assess each of the following variables for their qualities described as: (excellent, good, poor)
The 3 variables will be combined to describe intubation conditions as:
| after 60 seconds of rocuronium administration |
| Measure | Description | Time Frame |
|---|---|---|
| Heart rate | Following up the heart rate on the monitor | every minute of the first 5 minutes of intubation |
| Mean arterial pressure | Following up the mean arterial pressure by noninvasive blood pressure monitoring |
Not provided
Inclusion Criteria:
Exclusion Criteria:
Neuromuscular disease: myopathies
On drugs that interact with the neuromuscular junction or ephedrine
Cardiovascular disease: hypertension or ischemic heart disease
Increased risk of pulmonary aspiration:
Anticipated airway difficulties:
Hypersensitivity to any of the study drugs
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Ain Shams University Hospitals | Cairo | Egypt |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| ID | Term |
|---|---|
| D004809 | Ephedrine |
| ID | Term |
|---|---|
| D011412 | Propanolamines |
| D000605 | Amino Alcohols |
| D000438 | Alcohols |
| D009930 | Organic Chemicals |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Drug |
0.6 mg/kg |
|
| Rocuronium 0.8 | Drug | 0.8 mg/kg |
|
| Rocuronium 1.2 | Drug | 1.2 mg/kg |
|
| every minute of the first 5 minutes of intubation |
| D020005 |
| Propanols |
| D000588 | Amines |
| D010627 | Phenethylamines |
| D005021 | Ethylamines |